Here, we present further evidence that phosphorylated ILK (p-ILK) levels are higher in human ovarian cancer tissues compared with normal ovary samples, and that p-ILK levels relative to total ILK protein (p-ILK/ILK) are higher in cisplatin-resistant compared with cisplatin-sensitive ovarian cancer cells. The gene discussed is ILK; the disease is ovarian cancer.